UFFRF yields 1540.83% · JNJ yields 2.14%● Live data
📍 UFFRF pulled ahead of the other in Year 1
Combined, UFFRF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of UFFRF + JNJ for your $10,000?
Unifin Financiera, S. A. B. de C. V. operates as a leasing company in Mexico. The company operates through Leases, Factoring, and Others Loans segments. It provides leasing facilities for motor vehicles, such as cars, trucks, helicopters, aircraft, and ships; and machinery and equipment, as well as the assets of various industries in the middle-sized enterprise sector. The company also offers liquidity and financial solutions to customers by acquiring or discounting accounts receivables; financing for the working capital needs and the purchase of other capital goods; and granting loans for the acquisition of new or used vehicles to individuals and legal entities. In addition, it is involved in obtaining loans; guaranteeing obligations; and issuing, subscribing, accepting, endorsing, selling, discounting, and pledging various types of credits, as well as acting as administrator for guarantee trusts. Further, the company provides damage and theft, mayor medical expenses, auto, home, civil liability, life, and surety bail bonds insurance products. Unifin Financiera, S. A. B. de C. V. was incorporated in 1993 and is based in Mexico City, Mexico.
Full UFFRF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.